Nabil F. Saba, MD, FACP, is Professor and Vice Chair for Quality and Safety in the Department of Hematology and Medical Oncology and holds a joint appointment as Professor in the Department of Otolaryngology at Emory University School of Medicine. Dr. Saba serves as Director of the Head and Neck Cancer Medical Oncology Program at Winship Cancer Institute of Emory University. Dr. Saba is a recognized expert in immunotherapy for head and neck cancer. His work is focused on translational research and the study and development of novel therapeutic agents and modalities in head and neck and esophageal cancer. He leads several clinical trials and chairs national as well as investigator initiated multi-institution studies focusing on novel approaches for treating these diseases. Dr. Saba is the elected Chair of the National Cancer Institute's task force for recurrent metastatic head and neck cancer, and chaired the Rare Tumors Task Force of the National Cancer Institute's Head and Neck Cancer Steering Committee; he was recognized by the NCI for his outstanding service as committee chair. Dr. Saba is also an active member of the NRG Oncology and Eastern Cooperative Oncology Group (ECOG) Head and Neck Cancer Core Committees. In addition, Dr. Saba has been appointed as a member of the ASCO clinical guidelines committee as well as the ASCO Head and Neck Guideline Advisory Group.